Physician profile
Dana A Booth
NPI 1558511469
$13,234.63
in general payments reported to CMS, 2019-2025
27 companies · $6,268 in 2025
The $6,268 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $831 · 2020: $384 · 2021: $627 · 2022: $2,665 · 2023: $1,632 · 2024: $828 · 2025: $6,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,434 · Food and Beverage: $2,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,434.34 |
| Food and Beverage | $2,293.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,800.41 | 2021-2025 | |
| Abbott Laboratories | $2,411.88 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $1,285.42 | 2021-2024 | Pascal |
| Abiomed | $1,213.04 | 2019-2025 | Impella |
| Atricure, INC. | $421.53 | 2022-2024 | |
| Lemaitre Vascular, INC. | $283.32 | 2024-2025 | Xenosure Biologic Patch, Artegraft Vascular Graft |
| Medtronic, INC. | $254.01 | 2022-2024 | Corevalve Evolut R, Heli-Fx Endoanchor System, Avalus |
| Baxter Healthcare | $184.23 | 2022-2025 | Preveleak, Perclot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $178.86 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $169.46 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $153.62 | 2022-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $132.46 | 2021-2025 | |
| Ethicon US, LLC | $124.99 | 2022 | |
| Novo Nordisk INC | $112.48 | 2021 | |
| Novartis Pharmaceuticals Corporation | $107.72 | 2023-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $60.86 | 2020 | |
| Amgen INC. | $51.38 | 2020-2024 | Repatha |
| Angiodynamics, INC. | $45.92 | 2020 | |
| Kls-Martin L.P. | $34.74 | 2020 | |
| Inspire Medical Systems, INC. | $31.41 | 2025 | Inspire |
| Boston Scientific Corporation | $31.11 | 2020-2021 | |
| Artivion, INC. | $30.22 | 2025 | Amds-Ascyrus Medical |
| Livanova USA, INC. | $29.22 | 2022 | |
| Chiesi USA, INC. | $27.44 | 2019-2024 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $26.70 | 2023 | Xarelto |
| Haemonetics Corporation | $17.94 | 2024 | Teg6s Hemostasis System |
| Itamar Medical INC | $14.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Booth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.